Pan-Cancer Mapping of the Tumor Immune Landscape through Metagene Clustering and Predictive Modeling

ArXi:2603.27145v1 Announce Type: cross As immunotherapies become standard cancer treatments, it is increasingly important to identify a patient's immune profile, which encompasses the activity of immune cells within the tumor microenvironment and the presence of specific biomarkers. However, we lack mechanistic explanations drivers of immune phenotypes. Despite advances in immune profiling with high-throughput sequencing, the mechanisms driving them remain unclear.